| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on November 21, 2007
Accepted on May 8, 2008
From the University of Edinburgh/Medical Research Council (MRC) Centre for Inflammation Research (S.B., J.R., S.P.H., I.D.), Queen's Medical Research Institute, Edinburgh, UK; and the Centre for Cardiovascular Science (S.B., K.A.A.F.), University of Edinburgh, Queen's Medical Research Institute, Edinburgh, UK.
* To whom correspondence should be addressed. E-mail: i.dransfield{at}ed.ac.uk.
Objective—Acute coronary diseases are characterized by elevated levels of circulating platelet-leukocyte complexes, raising the possibility that proinflammatory processes might be initiated in leukocytes after platelet adhesion. Here we examined the mechanism of platelet binding to polymorphonuclear leukocytes, monocytes, and monocyte subsets and investigated the potential functional consequences of monocyte binding to minimally activated or thrombin-activated platelets.
Methods and Results—In this article, we describe key differences in terms of stability of PSGL-1–mediated interaction of platelets with monocytes and polymorphonuclear leukocytes and a small but significant difference in platelet binding to monocyte subsets (CD14high and CD14low/HLA-DRhigh). We also report differential effects of platelet binding on monocyte functional responses between minimally and thrombin-activated platelets. In particular, monocyte CD11b expression and release of proinflammatory cytokines, like interleukin 1
and tumor necrosis factor
, were significantly upregulated on adhesion of stimulated platelets, whereas unstimulated platelets had no effect. Moreover, binding of unstimulated, but not of thrombin-activated, platelets to monocytes had no impact on NF-
B activity, monocyte migration, and induction of apoptosis in the absence of survival factors.
Conclusions—Our data suggest that in the absence of overt activation, PSGL-1–P-selectin–dependent platelet binding to monocytes represents a normal physiological process with little impact on the potential of monocytes to cause vascular injury.
This article has been cited by other articles:
![]() |
S. Bournazos, S. P. Hart, L. H. Chamberlain, M. J. Glennie, and I. Dransfield Association of Fc{gamma}RIIa (CD32a) with Lipid Rafts Regulates Ligand Binding Activity J. Immunol., June 15, 2009; 182(12): 8026 - 8036. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. van Gils, J. J. Zwaginga, and P. L. Hordijk Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases J. Leukoc. Biol., February 1, 2009; 85(2): 195 - 204. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |